Lurasidone generic status december 2024?

As of December 2024, there was no FDA-approved generic version of lurasidone (Latuda) in the United States. Latuda remained brand-name only, with generic entry not yet approved in the US. The patent and exclusivity landscape for lurasidone suggested that generic availability would not be expected until the late 2020s, depending on patent expirations and any additional regulatory protections.

Notes:
- Generic status can vary by country. Some jurisdictions outside the US may have generic lurasidone available.
- Patent expiry and exclusivity details can change; for the most up-to-date status you can check:
- FDA Orange Book (patents and exclusivity for lurasidone in the US)
- Drugs@FDA or the FDA’s generic drug program listings
- The USPTO patent databases
- National/regulatory databases in your country (e.g., Health Canada, EMA/European national agencies)

If you’d like, tell me your country and I can outline the current status there or guide you to the exact sources to verify.